Table of Contents
Volume 8 | Issue 7
Publication Date: July 2007- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Edtiorial | ||
410-411 |
Optimizing Targeted Therapy in Patients with Lung Cancer with a Performance Status of 2 Primo N. Lara, Jr, Angela M. Davies |
|
Mini-Review | ||
413-419 |
The Potential of Death Receptor 4– and 5–Directed Therapies in the Treatment of Lung Cancer D. Ross Camidge |
|
Comprehensive Reviews | ||
420-424 |
Dual Inhibition: Combining Epidermal Growth Factor–Targeted Therapies in Non–Small-Cell Lung Cancer Cheryl Ho, Angela Davies, Philip Mack, David Gandara |
|
425-428 |
Erlotinib as a Single Agent in Select Subsets of Patients with Advanced Non–Small-Cell Lung Cancer Ramón Pérez Carrión, Antonio Cubillo Gracián, Pedro Salinas Hernandez |
|
Original Contribution | ||
429-433 |
ErbB4 Expression and Mutation in Japanese Patients with Lung Cancer Hidefumi Sasaki, Katsuhiro Okuda, Osamu Kawano, Katsuhiko Endo, Haruhiro Yukiue, Tomoki Yokoyama, Motoki Yano, Yoshitaka Fujii |
|
Case Reports | ||
434-435 |
Malignancy-Related Hypercalcemia Developing on a Bisphosphonate but Responding to Calcitonin Charles J. Diskin, Thomas J. Stokes, Linda M. Dansby, Lautrec Radcliff, Thomas B. Carter |
|
436-438 |
Metastatic Brain Mass Caused by Slow-Growing Small-Cell Lung Cancer: Differential Vascular Endothelial Growth Factor Expression in Primary and Metastatic Tumor Satoshi Inoue, Hisashi Oshiro, Yuji Watanuki, Naoki Miyazawa, Makoto Kudo, Hideto Goto, Jun Tsukiji, Takeshi Kaneko, Yoshiaki Ishigatsubo |
|
439-442 |
Dedifferentiated Chondrosarcoma of the Lung: Case Report and Review of the Literature Stefan Steurer, Monika Huber, Felix Lintner |
|
Clinical Trials | ||
456 |
Selected Clinical Trials in Lung Cancer CIG Media Group |
|